CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-05 | Heffernan Michael Thomas Director | Grant or award | +13,700 | 34,886 | ||
| 2020-06-05 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-05 | Enyedy Mark J Director | Grant or award | +13,700 | 31,143 | ||
| 2020-06-05 | Enyedy Mark J Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-05 | ADAMS ADRIAN Director | Grant or award | +13,700 | 77,400 | ||
| 2020-06-05 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-01 | Faulkingham Dell CCO | Sale | −6,426 | $11.58 | $74K | 73,574 |
| 2020-04-06 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +80,200 | 80,200 | ||
| 2020-02-28 | Dahan Michel SVP, Chief Operating Officer | Grant or award | +65,000 | 211,932 | ||
| 2020-02-28 | Dahan Michel SVP, Chief Operating Officer | Sale | −6,972 | $8.70 | $61K | 204,960 |
| 2020-02-28 | Dahan Michel SVP, Chief Operating Officer | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2020-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award | +62,000 | 219,806 | ||
| 2020-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −7,050 | $8.70 | $61K | 212,756 |
| 2020-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award · Stock Option (Right to buy) | +105,000 | 105,000 | ||
| 2020-02-28 | Amello Jason SVP, CFO & Treasurer | Grant or award | +30,000 | 151,618 | ||
| 2020-02-28 | Amello Jason SVP, CFO & Treasurer | Sale | −6,976 | $8.70 | $61K | 144,642 |
| 2020-02-28 | Amello Jason SVP, CFO & Treasurer | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2020-02-28 | Tubridy Karen L SVP, Chief Development Officer | Grant or award | +30,000 | 88,133 | ||
| 2020-02-28 | Tubridy Karen L SVP, Chief Development Officer | Sale | −3,454 | $8.70 | $30K | 84,679 |
| 2020-02-28 | Tubridy Karen L SVP, Chief Development Officer | Grant or award · Stock Option (Right to buy) | +85,000 | 85,000 |
Page 16 of 21 · 405 trades